Literature DB >> 21248439

Preoperative assessment and optimization in periampullary and pancreatic cancer.

S Myatra1, J V Divatia, B Jibhkate, G S Barreto, S V Shrikhande.   

Abstract

Perioperative management of pancreatic and periampullary cancer poses a considerable challenge to the pancreatic surgeon, anesthesiologist, and the intensive care team. The preoperative surgical evaluation of a pancreatic lesion aims to define the nature of the lesion (malignant or benign), stage the tumor, and to determine resectability or other non-surgical treatment options. Patients are often elderly and may have significant comorbidities and malnutrition. Obstructive jaundice may lead to coagulopathy, infection, renal dysfunction, and adverse outcomes. Routine preoperative biliary drainage can result in higher complication rates, and metal stents may be preferred over plastic stents in selected patients with resectable disease. Judicious use of antibiotics and maintaining fluid volume preoperatively can reduce the incidence of infection and renal dysfunction, respectively. Perioperative fluid therapy with hemodynamic optimization using minimally invasive monitoring may help improve outcomes. Careful patient selection, appropriate preoperative evaluation and optimization can greatly contribute to a favorable outcome after major pancreatic resections.

Entities:  

Mesh:

Year:  2011        PMID: 21248439     DOI: 10.4103/0019-509X.75839

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  2 in total

Review 1.  The safety and efficacy of nasobiliary drainage versus biliary stenting in malignant biliary obstruction: A systematic review and meta-analysis.

Authors:  Huapeng Lin; Shengwei Li; Xi Liu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

2.  A single-center retrospective study comparing safety and efficacy of endoscopic biliary stenting only vs. EBS plus nasobiliary drain for obstructive jaundice.

Authors:  Huan Liu; Chuanke Shi; Zhideng Yan; Ming Luo
Journal:  Front Med (Lausanne)       Date:  2022-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.